These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12583451)

  • 41. Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up study.
    Lohse N; Kronborg G; Gerstoft J; Larsen CS; Pedersen G; Pedersen C; Sørensen HT; Obel N
    Clin Infect Dis; 2006 Jan; 42(1):136-44. PubMed ID: 16323104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality.
    Pinto AN; Grey P; Shaik A; Cooper DA; Kelleher AD; Petoumenos K
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):936-941. PubMed ID: 29901415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART)].
    Pezzotti P; Dorrucci M; Donisi A; Cusini M; Mazzarello G; De Luca A; Salassa B; Ursitti MA; Giuliani M; Rezza G;
    Epidemiol Prev; 2003; 27(6):348-55. PubMed ID: 15058363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial.
    MacArthur RD; Novak RM; Peng G; Chen L; Xiang Y; Hullsiek KH; Kozal MJ; van den Berg-Wolf M; Henely C; Schmetter B; Dehlinger M; ;
    Lancet; 2006 Dec; 368(9553):2125-35. PubMed ID: 17174704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mortality and its predictors among highly active antiretroviral therapy naive hiv-infected individuals: data from prospective cohort study in Ukraine.
    Zhyvytsia D
    Georgian Med News; 2014; (232-233):69-74. PubMed ID: 25214276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunologic response to highly active antiretroviral therapy and mortality reduction in a cohort of human immunodeficiency virus-positive persons in Mozambique.
    Palombi L; Dorrucci M; Zimba I; Scarcella P; Mancinelli S; Buonomo E; Guidotti G; Marazzi MC; Rezza G
    Am J Trop Med Hyg; 2010 Nov; 83(5):1128-32. PubMed ID: 21036851
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection: impact on medical, palliative care, and quality of life outcomes.
    Brechtl JR; Breitbart W; Galietta M; Krivo S; Rosenfeld B
    J Pain Symptom Manage; 2001 Jan; 21(1):41-51. PubMed ID: 11223313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit.
    Casalino E; Wolff M; Ravaud P; Choquet C; Bruneel F; Regnier B
    AIDS; 2004 Jul; 18(10):1429-33. PubMed ID: 15199319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Women experience a better long-term immune recovery and a better survival on HAART in Lao People's Democratic Republic.
    Bastard M; Soulinphumy K; Phimmasone P; Saadani AH; Ciaffi L; Communier A; Phimphachanh C; Ecochard R; Etard JF
    BMC Infect Dis; 2013 Jan; 13():27. PubMed ID: 23339377
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between Body Mass Index and Mortality in HIV-Infected HAART Users in the Women's Interagency HIV Study.
    Sharma A; Hoover DR; Shi Q; Gustafson D; Plankey MW; Hershow RC; Tien PC; Golub ET; Anastos K
    PLoS One; 2015; 10(12):e0143740. PubMed ID: 26699870
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study.
    Dauby N; De Wit S; Delforge M; Necsoi VC; Clumeck N
    J Int AIDS Soc; 2011 Mar; 14():16. PubMed ID: 21443771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Survival rate of AIDS disease and mortality in HIV-infected patients: a meta-analysis.
    Poorolajal J; Hooshmand E; Mahjub H; Esmailnasab N; Jenabi E
    Public Health; 2016 Oct; 139():3-12. PubMed ID: 27349729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count.
    Cole SR; Hernán MA; Margolick JB; Cohen MH; Robins JM
    Am J Epidemiol; 2005 Sep; 162(5):471-8. PubMed ID: 16076835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy.
    Tang AM; Forrester J; Spiegelman D; Knox TA; Tchetgen E; Gorbach SL
    J Acquir Immune Defic Syndr; 2002 Oct; 31(2):230-6. PubMed ID: 12394802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short- and long-term outcome of HIV-infected patients admitted to the intensive care unit.
    van Lelyveld SF; Wind CM; Mudrikova T; van Leeuwen HJ; de Lange DW; Hoepelman AI
    Eur J Clin Microbiol Infect Dis; 2011 Sep; 30(9):1085-93. PubMed ID: 21331480
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influenza-related mortality among adults aged 25-54 years with AIDS in South Africa and the United States of America.
    Cohen C; Simonsen L; Sample J; Kang JW; Miller M; Madhi SA; Campsmith M; Viboud C
    Clin Infect Dis; 2012 Oct; 55(7):996-1003. PubMed ID: 22715173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and diagnostic value of brain biopsy in HIV patients: a case series and meta-analysis of 1209 patients.
    Lee AM; Bai HX; Zou Y; Qiu D; Zhou J; Martinez-Lage Alvarez M; Zhang P; Tao Y; Tang X; Xiao B; Yang L
    J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):722-33. PubMed ID: 26758989
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A further investigation of health-related quality of life over time among men with HIV infection in the HAART era.
    Jia H; Uphold CR; Zheng Y; Wu S; Chen GJ; Findley K; Duncan PW
    Qual Life Res; 2007 Aug; 16(6):961-8. PubMed ID: 17468942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival Among New Yorkers with HIV from 1981 to 2017: Inequities by Race/Ethnicity and Transmission Risk Persist into the Post-HAART Era.
    Braunstein SL; Kersanske L; Torian LV; Lazar R; Harriman G
    AIDS Behav; 2022 Jan; 26(1):284-293. PubMed ID: 34536177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessing the performance of a computer-based policy model of HIV and AIDS.
    Rydzak CE; Cotich KL; Sax PE; Hsu HE; Wang B; Losina E; Freedberg KA; Weinstein MC; Goldie SJ;
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.